Aizentx was founded by David Van Valen, Ajay Kshatriya in 2023.

Who are Aizentx's investors?

Aizentx's investors include Madrona Venture Group.

Where is Aizentx headquartered?

Aizentx is headquartered in San Diego, US.

Aizentx

San Diego, US · Founded 2023 · 16 employees on LinkedIn · 1 known investors

Find your way into Aizentx

1,950 people in our graph share verified history with the Aizentx team — schools, employers, funds. One of them is your warm intro.

Wesley Chanunlockedknows David Van Valen · together at Massachusetts Institute of Technology (overlapped)

×4knows the team · via Stanford University

×3knows the team · via Massachusetts Institute of Technology

×2knows the team · via UCLA

×2knows the team · via University of California, Berkeley, Haas School of Business

Aizen is an AI-native biotechnology company that designs novel oral peptides using non-canonical amino acids and an AI platform called DaX to treat chronic immune disorders. The company develops both proprietary therapeutics and partners with biopharma companies to advance gut-restricted and systemic oral biologics.

AI & Machine Learning Biotech Medical Devices

Founders & leadership

Aizentx was founded in 2023 by David Van Valen and Ajay Kshatriya.

David Van Valen inFounder, Caltech ProfessorDavid Van Valen is an Assistant Professor in the Division of Biology and Bioengineering at Caltech with degrees in mathematics and physics from MIT, a Ph.D. in applied physics from Caltech, an M.D. from UCLA, and postdoctoral training in bioengineering at Stanford; his research spans imaging, genomics, and machine learning for single-cell analysis.

Ajay Kshatriya inMBAAjay Kshatriya is CEO of Aizen Therapeutics, an AI-native biotech company developing oral peptides for chronic immune disorders. He previously founded Biota, an environmental genomics company acquired by Novozymes, and worked in venture capital at XSeed Capital and product operations at Genentech; he holds engineering degrees from UC Berkeley and Stanford and an MBA from Berkeley-Haas.

Bernhard GeierstangerinPhD

Todd PetersoninPhD

Investors · 1

Madrona Venture GroupSeattle · $2M – $10M

Competitors · 3

by search overlap

Bioworld6 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Clementia4 shared keywordsIpsen is a biopharmaceutical group that publishes financial, legal, and non-financial reporting for shareholders, investors, and the public through documents such as its Universal Registration Document. The page is the investor reports and accounts section of the company's corporate site.

IQVIA4 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.

Companies competing with Aizentx for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Aizentx do?: Aizen is an AI-native biotechnology company that designs novel oral peptides using non-canonical amino acids and an AI platform called DaX to treat chronic immune disorders. The company develops both proprietary therapeutics and partners with biopharma companies to advance gut-restricted and systemic oral biologics.
Who founded Aizentx?: Aizentx was founded by David Van Valen, Ajay Kshatriya in 2023.
Who are Aizentx's investors?: Aizentx's investors include Madrona Venture Group.
Where is Aizentx headquartered?: Aizentx is headquartered in San Diego, US.